procainamide has been researched along with Long QT Syndrome in 4 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "No arrhythmia was induced by lidocaine." | 1.40 | Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig. ( Osadchii, OE, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osadchii, OE | 1 |
| Ridley, JM | 1 |
| Milnes, JT | 1 |
| Benest, AV | 1 |
| Masters, JD | 1 |
| Witchel, HJ | 1 |
| Hancox, JC | 1 |
| Lazzara, R | 1 |
| Gardner, MJ | 1 |
| McCarthy, DM | 1 |
| Josephson, ME | 1 |
1 review available for procainamide and Long QT Syndrome
| Article | Year |
|---|---|
Mechanistic and clinical aspects of acquired long QT syndromes.
Topics: Action Potentials; Atrial Fibrillation; Electrocardiography; Humans; Long QT Syndrome; Procainamide; | 1992 |
3 other studies available for procainamide and Long QT Syndrome
| Article | Year |
|---|---|
Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Femal | 2014 |
Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.
Topics: Anti-Arrhythmia Agents; Cation Transport Proteins; Cell Line; Cell Membrane; Disopyramide; DNA-Bindi | 2003 |
Effect of myocardial ischemia and type I antiarrhythmic drug therapy on exercise QT intervals.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Disopyramide; Electrocardiography; Exercise Test; Heart Co | 1985 |